Showing results (21-30 of 69) with videos related to
Sort By:
Pageof 7
Journal of Forensic Sciences|August 14, 2012
An investigation of model forensic bone in soil environments studied using infrared spectroscopyJohanna M Howes, Barbara H Stuart, Paul S Thomas, et al.ANZ Journal of Surgery|July 2, 2009
Outcome of parathyroidectomy for patients with renal disease and hyperparathyroidism: predictors for recurrent hyperparathyroidismTsu-Hui Hubert Low, Jonathan Clark, Kan Gao, et al.The Laryngoscope|January 28, 2009
Outcomes of primary surgical treatment of T1 and T2 carcinomas of the oropharynxMarc Moncrieff, Jessica Sandilla, Jonathan Clark, et al.Australian Journal of Primary Health|December 9, 2022
Educational models, participant experience and outcomes of a diploma course in practice management for Aboriginal Medical Services: a qualitative studyParker Magin, Anthony Paulson, Christopher O'Brien, et al.Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|March 6, 2020
Outcomes After Direct-Acting Antiviral Therapy Based on Donor Hepatitis C Serostatus Among Hepatitis C Virus-Infected Kidney Transplant RecipientsMai Sedki, Camilo Cortesi, Christopher O'Brien, et al.International Journal of Cancer|April 7, 2009
Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary glandXiaoying Zhang, Murray Cairns, Barbara Rose, et al.Biochemical and Biophysical Research Communications|May 4, 2007
MicroRNA expression profiles in head and neck cancer cell linesNham Tran, Tessa McLean, Xiaoying Zhang, et al.Journal of Clinical Pharmacology|April 15, 2023
Model-Based Investigation of Inadequate Efficacy of Tesnatilimab, an Anti-Natural Killer Group 2 Member D Monoclonal Antibody, in Moderately to Severely Active Crohn DiseaseJie Zhou, Yan Xu, Yang Chen, et al.Journal of Hepatology|May 2, 2007
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 studyRobert G Gish, Sanjeev Arora, K Rajender Reddy, et al.Anticancer Research|June 30, 2016
Pilot Study of Intrahepatic Artery Chemotherapy in Combination with Sorafenib in Hepatocellular CarcinomaV Y Dinh, Shivank Bhatia, Govindarajan Narayanan, et al.Pageof 7